Across the recent three months, 9 analysts have shared their insights on Intellia Therapeutics (NASDAQ:NTLA), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 3 | 3 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 1 | 3 | 0 | 0 |
| 2M Ago | 1 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $46.56, a high estimate of $88.00, and a low estimate of $18.00. A 17.96% drop is evident in the current average compared to the previous average price target of $56.75.
Understanding Analyst Ratings: A Comprehensive Breakdown
The analysis of...
Login or create a forever free account to read this news
Sign up/Log in
